Gritstone announced an approximately 40% reduction of its workforce. The move comes following the recently announced delay of the proposed CORAL Phase 2b study, which resulted in Gritstone not receiving external funding it previously anticipated beginning in 1Q 2024, associated with the initiation of the study.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GRTS:
- Apollo Global upgraded, Dell initiated: Wall Street’s top analyst calls
- Gritstone initiated with an Outperform at JMP Securities
- Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
- Gritstone Oncology Postpones Phase 2b COVID-19 Vaccine Trial
- Gritstone announces update to comparative Phase 2b COVID-19 trial
